The Ambulatory Specialty Model (ASM) has the potential to reduce chronic disease costs by holding specialists accountable for ...

This indicates that rusfertide works for patients broadly rather than only for a subset, he explained. For durability, ...

D’Amico concluded that remigromig is the first biologic with a novel mechanism of action that demonstrated a noninferior ...

Michael Mina, MD, PhD, of Invivyd explains how a few amino acid changes let VYD2311 move from IV to a single IM shot that ...

Health literacy in cancer care is increasingly being treated as something health systems build rather than a ready skill ...

Fathi, of Mass General Brigham Cancer Institute, says PARADIGM trial data support azacitidine-venetoclax for ...

A 2024 protocol published in BMJ Open, outlining a planned systematic review to quantify that excess burden worldwide, noted ...

Joanna Parga-Belinkie, MD, explains how framing VKDB as a stroke and documenting refusals helps her counsel parents on ...

Medicare beneficiaries using lower-priced negotiated drugs experienced out-of-pocket savings under the Medicare Drug Price ...

Delphi consensus guides dermatology on spotting CTCL vs atopic dermatitis before/after dupilumab, using biopsy plus T-cell ...

Quantitative computed tomography (CT) methods can help predict disease progression and assess the efficacy of drugs in ...

Ask about burning, stinging, and facial warmth, and use dermoscopy or diascopy to spot rosacea when redness is hard to see.